Vor Biopharma
Mary Bronchetti Swartz is an experienced professional in the field of quality control and laboratory operations, currently serving as Senior Director of Quality at Vor Bio since September 2023. Prior to this role, Mary held significant positions including Head of QC Product Testing and Laboratory Logistics at Resilience and Associate Director - Large Molecule QC Lead at Takeda. With a strong background in quality control, Mary has contributed to various companies such as Shire, SRCTec, Bristol-Myers Squibb, Adecco Staffing, and Stiefel, a GSK company, where responsibilities encompassed leading technical research, executing validation protocols, and conducting potency assessments in biologics quality control laboratories. Mary holds a Bachelor of Science in Biochemistry from Union College and a Graduate Certificate in Bioprocess Engineering from the SUNY School of Environmental Science and Forestry.
This person is not in any teams
This person is not in any offices
Vor Biopharma
3 followers
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer. It is focused on developing technologies that can enable selective targeting of cancer cells without impacting normal cells.